Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

This biotech has candidates in late-stage clinical development.

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how involving procurement ...

J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...

At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to ...

In drug development, success often hinges on a deceptively simple question: how will the body respond? For Dr. Kidochukwu ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

The funding will focus on three key areas: fundamental AI, applied AI and talent development. Read more at straitstimes.com.

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...